Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

A 3D Niche Nanobioreactor Supports Long-Term Tracking of Hematopoietic Stem and Progenitor Cell Cycle Kinetics, Self-Renewal and Cell Fate Determination

Jenna S Sneifer, Jessica Pham, Inge Van Der Werf, Larissa Balaian, Emma E Klacking, Neha Katragadda, Luisa Ladel, Anna Kulidjian, Patrick Chang, Thomas Whisenant, Catriona Jamieson

Blood (2024) 144 (Supplement 1): 4068.

https://doi.org/10.1182/blood-2024-212259

Published: 2024

Journal Articles

Space-Associated Stem and Hematopoietic Cell Aging in Astronauts on Short-Duration Missions

Jessica Pham, Larissa Balaian, Patrick Chang, Shuvro P Nandi, Jenna S Sneifer, Antonio W Ruiz, Emma E Klacking, Inge Van Der Werf, Karla Mack, Neha Katragadda, Claire Engstrom, Cristian Quintero, Jane Isquith, Pinar Mesci, Elsa Molina, Jana Stoudemire, Thomas Whisenant, Ludmil Alexandrov, Catriona Jamieson

Blood (2024) 144 (Supplement 1): 5628.

https://doi.org/10.1182/blood-2024-212357

Published: 2024

Journal Articles

Identifying the Impact of ADAR1 Inhibition on LSC Niche Remodeling in 3D Nanobioreactors

Larissa Balaian, Jessica Pham, Anna Kulidjian, Edward D. Ball, Thomas Whisenant, Michael Burkart, Catriona Jamieson

Blood (2024) 144 (Supplement 1): 1385.

https://doi.org/10.1182/blood-2024-211696

Published: 2024

Journal Articles

A Longitudinal Study to Assess Hematopoietic Stem Cell and Immune Cell Health in Astronauts Pre-, during, and Post-Mission

Jessica Pham, Larissa Balaian, Emma E Klacking, Antonio W Ruiz, Jenna Sneifer, Thomas P Frias, Jane Isquith, Shuvro P Nandi, Thomas Whisenant, Elsa Molina, Jana Stoudemire, Pinar Mesci, Ludmil Alexandrov, Catriona Jamieson

Blood (2023) 142 (Supplement 1): 4056.

https://doi.org/10.1182/blood-2023-187749

Published: 2023

Journal Articles

Modeling Premalignant Transformation of Hematopoietic Stem Cells in a Nanobioreactor in Microgravity

Luisa Ladel, Jessica Pham, Larissa Balaian, Kathleen Steel, Isabelle Oliver, Catriona Jamieson

Blood (2022) 140 (Supplement 1): 2982–2983.

https://doi.org/10.1182/blood-2022-168138

Published: 2022

Journal Articles

Cirmtuzumab (Zilovertamab) Eliminates ROR1 Positive Leukemia Stem Cells By Blocking Niche Dependent ROR1/WNT5a Signaling

Larissa Balaian, Mary Donohoe, Phoebe Mondala, George F. Widhopf II, Emanuela M. Ghia, Edward D. Ball, Anna Kulidjian, Inge Van Der Werf, Thomas J. Kipps, Catriona Jamieson

Blood (2022) 140 (Supplement 1): 3356–3357.

https://doi.org/10.1182/blood-2022-170128

Published: 2022

Journal Articles

Decreased Embryonic Splicing Repressor Expression Enhances Splicing Modulator Sensitivity in Pediatric Acute Myeloid Leukemia Stem Cells

Inge Van Der Werf, Kathleen Steel, Phoebe Mondala, Larissa Balaian, Jacqueline Cloos, Gertjan J.L. Kaspers, James La Clair, Peggy Wentworth, Kathleen Fisch, Leslie Crews, Thomas Whisenant, Michael Burkart, Mary Donohoe, Catriona Jamieson

Blood (2022) 140 (Supplement 1): 3354–3355.

https://doi.org/10.1182/blood-2022-171145

Published: 2022

Journal Articles

Selective Targeting of Alternative Splicing Deregulation in Pediatric Acute Myeloid Stem and Progenitor Cells

Inge Van Der Werf, MSc, Phoebe Mondala, BS, Raymond Diep, BS, Larissa Balaian, PhD, Cayla Mason, BS, Jacqueline Cloos, PhD, Gertjan J.L. Kaspers, Prof. MD PhD, Jim La Clair, Peggy Wentworth, Leslie A Crews, PhD, Thomas Whisenant, PhD, Kathleen Fisch, PhD, Michael Burkart, PhD, Catriona Jamieson, MD PhD

Blood (2020) 136 (Supplement 1): 8.

https://doi.org/10.1182/blood-2020-136596

Published: 2020

Journal Articles

Imetelstat Inhibits Telomerase and Prevents Propagation of ADAR1-Activated Myeloproliferative Neoplasm and Leukemia Stem Cells

Wenxue Ma, MD PhD, Larissa Balaian, PhD, Phoebe Mondala, BS, Yudou He, BS, Cayla Mason, BS, Jessica Pham, B.S., Jeremy Lee, BS, Raymond Diep, BS, Sanja Coso, PhD, Kathleen Fisch, PhD, Adam Mark, MS, Sheldon Morris, MD MPH, Qingfei Jiang, PhD, Thomas Whisenant, PhD, Aleksandra Rizo, MD PhD, Fei Huang, PhD, Mary Donohoe, PhD, Ludmil Alexandrov, PhD, Catriona Jamieson, MD PhD

Blood (2020) 136 (Supplement 1): 18.

https://doi.org/10.1182/blood-2020-140771

Published: 2020

Journal Articles

Comparative Inflammasome Analysis of Bone Marrow Stroma in Aging and Myelofibrosis

Larissa Balaian, PhD, Leslie A Crews, PhD, Cayla Mayson, BS, Frida Holm, PhD, Raymond H Diep, Heather Leu, BS, Anna Kulidjian, MD, Edward D. Ball, MD, Catriona Jamieson, MD PhD

Blood (2018) 132 (Supplement 1): 4331.

https://doi.org/10.1182/blood-2018-99-118993

Published: 2018

Journal Articles

Telomerase Inhibition Impairs Self-Renewal of ß-Catenin Activated Myeloproliferative Neoplasm Progenitors

Wenxue Ma, MD PhD, Cayla Mason, BS, Ping Chen, MD PhD, Qingfei Jiang, PhD, Nathan Delos Santos, BS, Elisa Lazzari, PhD, Sheldon Morris, MD MPH, Phoebe Mondala, BS, Jane Isquith, BS, MS, Fei Huang, PhD, Larissa Balaian, PhD, Catriona Jamieson, MD PhD

Blood (2017) 130 (Supplement 1): 2860.

https://doi.org/10.1182/blood.V130.Suppl_1.2860.2860

Published: 2017

Journal Articles

RNA Splicing Modulation Impairs Acute Myeloid Leukemia Stem Cell Maintenance

Leslie A Crews, PhD, Larissa Balaian, PhD, Heather Leu, BS, Nathaniel Delos Santos, Angela C Court, Anil Sadarangani, PhD, Maria A. Zipeto, PhD, James J La Clair, Reymundo Villa, Sheldon Morris, MD, Rainer F. Storb, MD, Anna Kulidjian, MD, Edward D. Ball, MD, Michael D Burkart, PhD, Catriona Jamieson, MD PhD

Blood (2015) 126 (23): 567.

https://doi.org/10.1182/blood.V126.23.567.567

Published: 2015

Journal Articles

SHH Inhibitor PF-0449913 in Vitro Remodels Leukemic Niche into HSC Supportive Niche

Larissa Balaian, PhD, Leslie C. Robertson, PhD, Anna Kulidjian, MD, Edward D. Ball, MD, Catriona Jamieson, MD PhD

Blood (2014) 124 (21): 4784.

https://doi.org/10.1182/blood.V124.21.4784.4784

Published: 2014

Journal Articles

A Highly Selective SF3B1-Targeted Splicing Inhibitor Reduces Human CD34+ Cell Survival and Self-Renewal In Acute Myeloid Leukemia

Larissa Balaian, Ph.D., Leslie A Crews, PhD, Marianna Zipeto, Kulidjian Anna, MD, Edward D. Ball, M.D., Michael D Burkart, PhD, Catriona HM Jamieson, MD, PhD

Blood (2013) 122 (21): 1653.

https://doi.org/10.1182/blood.V122.21.1653.1653

Published: 2013

Journal Articles

A Highly Selective Anti-ROR1 Monoclonal Antibody Inhibits Human Acute Myeloid Leukemia CD34+ Cell Survival and Self-Renewal.

Larissa Balaian, Ph.D., Anil Sadarangani, Ph.D., George F. Widhopf, II, PhD, Rui-kun Zhong, MD, Charles Prussak, PhD, Marco A. Marra, PhD, John E Dick, PhD, Mark D. Minden, MD, PhD, Edward D. Ball, M.D., Dennis A. Carson, M.D., Catriona Jamieson, MD, PhD, Thomas J. Kipps, MD, PhD

Blood (2012) 120 (21): 2560.

https://doi.org/10.1182/blood.V120.21.2560.2560

Published: 2012

Journal Articles

Update of a Phase I/II Trial of 5-Azacytidine Prior to Gemtuzumab Ozogamicin (GO) for Patients with Relapsed Acute Myeloid Leukemia with Correlative Biomarker Studies

Edward D. Ball, MD, Bruno C. Medeiros, MD, Larissa Balaian, PhD, Tracy Roque, Sue Corringham, Richa Rajwanshi, Steven Coutre, Jason R Gotlib, MD, MS, Asad Bashey, MD, PhD, Karen Messer

Blood (2010) 116 (21): 3286.

https://doi.org/10.1182/blood.V116.21.3286.3286

Published: 2010

Journal Articles

A Novel Mouse Xenograft Model for Generation of JAK2 V617F Driven Leukemic Stem Cells From Human Embryonic Stem Cells.

Edward Kavalerchik, MD, Charlene Barroga, PhD, Larissa Balaian, PhD, Jennifer M. Black, MD, Catriona H.M. Jamieson, MD, PhD

Blood (2009) 114 (22): 1433.

https://doi.org/10.1182/blood.V114.22.1433.1433

Published: 2009

Journal Articles

A Phase I/II Trial of 5-Azacytidine Prior to Gemtuzumab Ozogamicin (GO) for Patients with Relapsed Acute Myeloid Leukemia with Correlative Biomarker Studies.

D Ball Edward, MD, Bruno C. Medeiros, MD, Larissa Balaian, PhD, Tracy Roque, Sue Corringham, RN, Richa Rajwanshi, Steve Coutre, MD, Jason R Gotlib, MD, MS, Asad Bashey, MD, PhD, Karen Messer, PhD

Blood (2009) 114 (22): 2049.

https://doi.org/10.1182/blood.V114.22.2049.2049

Published: 2009

Journal Articles

5-Azacytidine Potentiates the Anti-Proliferative Activity of Anti-CD33 Monoclonal Antibodies (mAb) in Acute Myeloid Leukemia in Part through Induction of Syk and SHP-1 Expression.

Larissa Balaian, PhD, Edward D. Ball, MD

Blood (2005) 106 (11): 2459.

https://doi.org/10.1182/blood.V106.11.2459.2459

Published: 2005

Journal Articles

The Anti-Proliferative Effect of Immunotoxin Gemtuzimab Ozogamycin (GO) (Mylotarg) to Acute Myeloid Leukemia (AML) Cells Is Associated with the Level of Protein Kinase Syk Exspression.

Larissa Balaian, Ph.D, Edward D. Ball, MD

Blood (2004) 104 (11): 96.

https://doi.org/10.1182/blood.V104.11.96.96

Published: 2004

NARROW

A 3D Niche Nanobioreactor Supports Long-Term Tracking of Hematopoietic Stem and Progenitor Cell Cycle Kinetics, Self-Renewal and Cell Fate Determination

Space-Associated Stem and Hematopoietic Cell Aging in Astronauts on Short-Duration Missions

Identifying the Impact of ADAR1 Inhibition on LSC Niche Remodeling in 3D Nanobioreactors

A Longitudinal Study to Assess Hematopoietic Stem Cell and Immune Cell Health in Astronauts Pre-, during, and Post-Mission

Modeling Premalignant Transformation of Hematopoietic Stem Cells in a Nanobioreactor in Microgravity

Cirmtuzumab (Zilovertamab) Eliminates ROR1 Positive Leukemia Stem Cells By Blocking Niche Dependent ROR1/WNT5a Signaling

Decreased Embryonic Splicing Repressor Expression Enhances Splicing Modulator Sensitivity in Pediatric Acute Myeloid Leukemia Stem Cells

Selective Targeting of Alternative Splicing Deregulation in Pediatric Acute Myeloid Stem and Progenitor Cells

Imetelstat Inhibits Telomerase and Prevents Propagation of ADAR1-Activated Myeloproliferative Neoplasm and Leukemia Stem Cells

Comparative Inflammasome Analysis of Bone Marrow Stroma in Aging and Myelofibrosis

Telomerase Inhibition Impairs Self-Renewal of ß-Catenin Activated Myeloproliferative Neoplasm Progenitors

RNA Splicing Modulation Impairs Acute Myeloid Leukemia Stem Cell Maintenance

SHH Inhibitor PF-0449913 in Vitro Remodels Leukemic Niche into HSC Supportive Niche

A Highly Selective SF3B1-Targeted Splicing Inhibitor Reduces Human CD34+ Cell Survival and Self-Renewal In Acute Myeloid Leukemia

A Highly Selective Anti-ROR1 Monoclonal Antibody Inhibits Human Acute Myeloid Leukemia CD34+ Cell Survival and Self-Renewal.

Update of a Phase I/II Trial of 5-Azacytidine Prior to Gemtuzumab Ozogamicin (GO) for Patients with Relapsed Acute Myeloid Leukemia with Correlative Biomarker Studies

A Novel Mouse Xenograft Model for Generation of JAK2 V617F Driven Leukemic Stem Cells From Human Embryonic Stem Cells.

A Phase I/II Trial of 5-Azacytidine Prior to Gemtuzumab Ozogamicin (GO) for Patients with Relapsed Acute Myeloid Leukemia with Correlative Biomarker Studies.

5-Azacytidine Potentiates the Anti-Proliferative Activity of Anti-CD33 Monoclonal Antibodies (mAb) in Acute Myeloid Leukemia in Part through Induction of Syk and SHP-1 Expression.

The Anti-Proliferative Effect of Immunotoxin Gemtuzimab Ozogamycin (GO) (Mylotarg) to Acute Myeloid Leukemia (AML) Cells Is Associated with the Level of Protein Kinase Syk Exspression.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only